Table 1.

Baseline demographics and drug use

	Naltrexone n=20	Methadone n=16
Age in years (SD)	37.45 (9.25)	41.18 (9.49)
Male n(%)	16(80.0)	11(68.7)
Race n(%)
White	10 (50.0)	9 (56.2)
Hispanic	5 (25.0)	5 (31.3)
African-American	4 (20.0)	2 (12.5)
Other	1 (5.0)	0 (0.0)
Employed* n (%)	10 (50.0)	3 (18.8)
Domiciled n (%)	20(100)	16(100)
Highest level of education n (%)
grade school	6 (30.0)	3 (18.8)
high school	5 (25.0)	7 (43.7)
at least some college	9 (45.0)	6 (37.5)
Diabetes n (%)
no diagnosis	19 (95.0)	16 (100.0)
Diagnosed, untreated	0 (0.0)	0 (0.0)
Diagnosed, treated	1 (5.0)	0 (0.0)
Hypertension n (%)
no diagnosis	18 (90.0)	13 (81.2)
diagnosed, untreated	0 (0.0)	2 (12.5)
diagnosed, treated	2 (10.0)	1 (6.3)
Mood disorder n (%)
no diagnosis	11 (55.0)	11 (68.8)
diagnosed, untreated	8 (40.0)	2 (12.5)
diagnosed, treated	1 (5.0)	3 (18.7)
Psychotic disorder n(%)
no diagnosis	19 (95.0)	15 (93.7)
diagnosed, untreated	1 (5.0)	0 (0.0)
diagnosed, treated	0 (0.0)	1 (6.3)
Daily heroin bags^ (SD)	6.03 (3.59)	8.18 (5.76)
IV heroin ^ n(%)	9(45.0)	11(68.8)
Daily drinks of alcohol (SD)	0.50 (1.00)	0.56 (1.63)
Daily packs cigarettes(SD)	0.68 (0.44)	0.57 (0.51)
Daily $’s on cocaine (SD)	3.80 (10.82)	2.06 (7.48)
Daily marijuana joints (SD)	0.42 (0.99)	.13 (0.34)

^*significance of difference between groups p<=0.5

^{^}n=11 methadone and n=18 naltrexone patients used heroin at baseline